Health Care & Life Sciences » Biotechnology | Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
6.53 M
Public Float
-
Santhera Pharmaceuticals Holding AG
Stock Exchange SIX Swiss Exchange
EPS
CHF7.86
Market Cap
CHF169.34 M
Shares Outstanding
11.16 M
Public Float
8.21 M

Profile

Address
Hohenrainstrasse 24
Pratteln Basel-Landschaft (Basle Country) 4133
Switzerland
Employees -
Website http://www.santhera.com
Updated 07/08/2019
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands.

Financials

View All

Thomas Meier
Chief Executive Officer & Director
Martin Gertsch
Vice Chairman